CHAMPIONS ONCOLOGY, INC. Depreciation
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Depreciation of $254.00 thousand for the 3-month period ending 2020-10-31, per its 10-Q filed 2020-12-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2020-12-14
- CHAMPIONS ONCOLOGY, INC. depreciation for the quarter ending 2020-10-31 was $254.00K, a 56.79% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. depreciation for the quarter ending 2020-07-31 was $224.00K, a 54.48% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. depreciation for the quarter ending 2020-01-31 was $184.00K, a 44.88% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. depreciation for the quarter ending 2019-10-31 was $162.00K, a 40.87% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. depreciation for fiscal 2014 was $213.00K, a 4.93% increase from fiscal 2013.
- CHAMPIONS ONCOLOGY, INC. depreciation for fiscal 2013 was $203.00K, a 93.33% increase from fiscal 2012.
- CHAMPIONS ONCOLOGY, INC. depreciation for fiscal 2012 was $105.00K, a 150.00% increase from fiscal 2011.
- CHAMPIONS ONCOLOGY, INC. depreciation for fiscal 2011 was $42.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2020-10-31 | $254.00K 10-Q · filed 2020-12-14 | $478.00K 10-Q · filed 2020-12-14 | ||||
| 2020-07-31 | $224.00K 10-Q · filed 2020-09-14 | |||||
| 2020-01-31 | $184.00K 10-Q · filed 2020-03-16 | $346.00K derived: sum of 2 quarters · filed 2020-12-14 | $491.00K 10-Q · filed 2020-03-16 | |||
| 2019-10-31 | $162.00K 10-Q · filed 2020-12-14 | $307.00K 10-Q · filed 2020-12-14 | ||||
| 2019-07-31 | $145.00K 10-Q · filed 2020-09-14 | |||||
| 2019-01-31 | $127.00K 10-Q · filed 2020-03-16 | $242.00K derived: sum of 2 quarters · filed 2020-03-16 | $353.00K 10-Q · filed 2020-03-16 | |||
| 2018-10-31 | $115.00K 10-Q · filed 2019-12-16 | $226.00K 10-Q · filed 2019-12-16 | ||||
| 2018-07-31 | $111.00K 10-Q · filed 2019-09-16 | |||||
| 2018-01-31 | $98.00K 10-Q · filed 2019-03-18 | $181.00K derived: sum of 2 quarters · filed 2019-03-18 | $233.00K 10-Q · filed 2019-03-18 | |||
| 2017-10-31 | $83.00K 10-Q · filed 2018-12-17 | $97.00K 10-Q · filed 2017-12-15 | $119.00K 10-Q · filed 2018-12-17 | |||
| 2017-07-31 | $36.00K 10-Q · filed 2018-09-14 | |||||
| 2017-01-31 | $34.00K 10-Q · filed 2018-03-19 | $68.00K derived: sum of 2 quarters · filed 2018-03-19 | $108.00K 10-Q · filed 2018-03-19 | |||
| 2016-10-31 | $34.00K 10-Q · filed 2017-12-15 | $74.00K 10-Q · filed 2017-12-15 | ||||
| 2016-07-31 | $39.00K 10-Q · filed 2017-09-14 | |||||
| 2016-01-31 | $31.00K 10-Q · filed 2017-03-17 | $62.00K derived: sum of 2 quarters · filed 2017-03-17 | $95.00K 10-Q · filed 2017-03-17 | |||
| 2015-10-31 | $31.00K 10-Q · filed 2016-12-14 | $64.00K 10-Q · filed 2016-12-14 | ||||
| 2015-07-31 | $37.00K 10-Q · filed 2016-09-14 | |||||
| 2015-01-31 | $52.00K 10-Q · filed 2016-03-16 | $106.00K derived: sum of 2 quarters · filed 2016-03-16 | $166.00K 10-Q · filed 2016-03-16 | $217.00K derived: sum of 4 quarters · filed 2016-03-16 | ||
| 2014-10-31 | $54.00K 10-Q · filed 2015-12-15 | $54.00 10-Q · filed 2014-12-15 | $110.00K 10-Q · filed 2015-12-15 | $110.00 10-Q · filed 2014-12-15 | $165.00K derived: sum of 3 quarters · filed 2015-12-15 | $221.00K derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | $56.00K 10-Q · filed 2015-09-11 | $111.00K derived: sum of 2 quarters · filed 2015-09-11 | $167.00K derived: sum of 3 quarters · filed 2015-09-11 | $167.05K derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2014-04-30 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | $111.00K derived: sum of 2 quarters · filed 2015-03-17 | $111.05K derived: sum of 3 quarters · filed 2015-03-17 | $213.00K 10-K · filed 2014-07-28 | ||
| 2014-01-31 | $56.00K 10-Q · filed 2015-03-17 | $56.05K derived: sum of 2 quarters · filed 2015-03-17 | $158.00K 10-Q · filed 2015-03-17 | $156.05K derived: sum of 4 quarters · filed 2015-03-17 | ||
| 2013-10-31 | $53.00 10-Q · filed 2014-12-15 | $53.00K 10-Q · filed 2013-12-13 | $102.00 10-Q · filed 2014-12-15 | $102.00K 10-Q · filed 2013-12-13 | $100.05K derived: sum of 3 quarters · filed 2014-12-15 | $151.05K derived: sum of 4 quarters · filed 2014-12-15 |
| 2013-07-31 | $50.00K 10-Q · filed 2014-09-12 | $100.00K derived: sum of 2 quarters · filed 2014-09-12 | $151.00K derived: sum of 3 quarters · filed 2014-09-12 | $200.00K derived: sum of 4 quarters · filed 2014-09-12 | ||
| 2013-04-30 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | $101.00K derived: sum of 2 quarters · filed 2014-07-28 | $150.00K derived: sum of 3 quarters · filed 2014-07-28 | $203.00K 10-K · filed 2014-07-28 | ||
| 2013-01-31 | $51.00K 10-Q · filed 2014-03-14 | $100.00K derived: sum of 2 quarters · filed 2014-03-14 | $153.00K 10-Q · filed 2014-03-14 | $194.00K derived: sum of 4 quarters · filed 2014-03-14 | ||
| 2012-10-31 | $49.00K 10-Q · filed 2013-12-13 | $103.00K 10-Q · filed 2013-12-13 | $143.00K derived: sum of 3 quarters · filed 2013-12-13 | $159.00K derived: sum of 4 quarters · filed 2013-12-13 | ||
| 2012-07-31 | $54.00K 10-Q · filed 2013-09-13 | $94.00K derived: sum of 2 quarters · filed 2013-09-13 | $110.00K derived: sum of 3 quarters · filed 2013-09-13 | $131.00K derived: sum of 4 quarters · filed 2013-09-13 | ||
| 2012-04-30 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | $56.00K derived: sum of 2 quarters · filed 2013-07-26 | $77.00K derived: sum of 3 quarters · filed 2013-07-26 | $105.00K 10-K · filed 2013-07-26 | ||
| 2012-01-31 | $16.00K 10-Q · filed 2013-03-13 | $37.00K derived: sum of 2 quarters · filed 2013-03-13 | $65.00K 10-Q · filed 2013-03-13 | $78.00K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-10-31 | $21.00K 10-Q · filed 2012-12-13 | $49.00K 10-Q · filed 2012-12-13 | $62.00K derived: sum of 3 quarters · filed 2012-12-13 | $72.00K derived: sum of 4 quarters · filed 2012-12-13 | ||
| 2011-07-31 | $29.00K 10-Q · filed 2012-09-12 | $41.00K derived: sum of 2 quarters · filed 2012-09-12 | $51.00K derived: sum of 3 quarters · filed 2012-09-12 | $61.00K derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $22.00K derived: sum of 2 quarters · filed 2012-07-18 | $32.00K derived: sum of 3 quarters · filed 2012-07-18 | $42.00K 10-K · filed 2012-07-18 | ||
| 2011-01-31 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $20.00K derived: sum of 2 quarters · filed 2012-03-14 | $30.00K 10-Q · filed 2012-03-14 | |||
| 2010-10-31 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14 | $20.00K 10-Q · filed 2011-12-14 | ||||
| 2010-07-31 | $10.00K 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |